Allodynia and hyperalgesia suppression by a novel analgesic in experimental neuropathic pain

Jian Guo Cui, Xiong Zhang, Yu Hai Zhao, Chu Chen, Nicolas Bazan

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

SCP-1, n-[α-(benzisothiazol-3(2ho-ona,1-dioxide-2yl)-acetyl]-p-aminophenol (100 nmol), when intrathecally injected, suppressed tactile allodynia and thermal hyperalgesia in a rat neuropathic pain model. The tactile allodynia suppression lasted for at least 4 h and SCP-M1 (100 nmol), the main metabolite of SCP-1, displayed similar suppression as SCP-1, but shorter latency, indicating SCP-M1 may be the bioactive component of SCP-1. Acetaminophen was less potent than SCP-1 and SCP-M1. To study mechanisms underlying SCP-1 action, we recorded voltage-gated Ca2+ channel currents in acutely isolated dorsal root ganglion neurons using the whole-cell patch-clamp technique. SCP-1 and SCP-M1 inhibited non-L-type calcium channel currents up to 23.0 ± 2.3% and 23.1 ± 3.5%, respectively, at a depolarized pulse to -10 mV from a holding potential of -80 mV. Acetaminophen only induced 6.8 ± 1.0% inhibition. The results suggest SCP-1 possesses anti-nociceptive activity in the rat model involving calcium channel blocking properties.

Original languageEnglish
Pages (from-to)358-363
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume350
Issue number2
DOIs
StatePublished - Nov 17 2006

Fingerprint

Hyperalgesia
Neuralgia
Analgesics
Calcium Channels
Acetaminophen
Rats
SCP 1
Clamping devices
Spinal Ganglia
Patch-Clamp Techniques
Metabolites
Neurons
Electric potential

Keywords

  • Behavioral test
  • Calcium channel
  • Neuropathic pain
  • Patch-clamp
  • Rat
  • SCP-1
  • Tactile allodynia
  • Thermal hyperalgesia

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Allodynia and hyperalgesia suppression by a novel analgesic in experimental neuropathic pain. / Cui, Jian Guo; Zhang, Xiong; Zhao, Yu Hai; Chen, Chu; Bazan, Nicolas.

In: Biochemical and Biophysical Research Communications, Vol. 350, No. 2, 17.11.2006, p. 358-363.

Research output: Contribution to journalArticle

Cui, Jian Guo ; Zhang, Xiong ; Zhao, Yu Hai ; Chen, Chu ; Bazan, Nicolas. / Allodynia and hyperalgesia suppression by a novel analgesic in experimental neuropathic pain. In: Biochemical and Biophysical Research Communications. 2006 ; Vol. 350, No. 2. pp. 358-363.
@article{ab95c5d09d31490b9e7e6dcde002eba1,
title = "Allodynia and hyperalgesia suppression by a novel analgesic in experimental neuropathic pain",
abstract = "SCP-1, n-[α-(benzisothiazol-3(2ho-ona,1-dioxide-2yl)-acetyl]-p-aminophenol (100 nmol), when intrathecally injected, suppressed tactile allodynia and thermal hyperalgesia in a rat neuropathic pain model. The tactile allodynia suppression lasted for at least 4 h and SCP-M1 (100 nmol), the main metabolite of SCP-1, displayed similar suppression as SCP-1, but shorter latency, indicating SCP-M1 may be the bioactive component of SCP-1. Acetaminophen was less potent than SCP-1 and SCP-M1. To study mechanisms underlying SCP-1 action, we recorded voltage-gated Ca2+ channel currents in acutely isolated dorsal root ganglion neurons using the whole-cell patch-clamp technique. SCP-1 and SCP-M1 inhibited non-L-type calcium channel currents up to 23.0 ± 2.3{\%} and 23.1 ± 3.5{\%}, respectively, at a depolarized pulse to -10 mV from a holding potential of -80 mV. Acetaminophen only induced 6.8 ± 1.0{\%} inhibition. The results suggest SCP-1 possesses anti-nociceptive activity in the rat model involving calcium channel blocking properties.",
keywords = "Behavioral test, Calcium channel, Neuropathic pain, Patch-clamp, Rat, SCP-1, Tactile allodynia, Thermal hyperalgesia",
author = "Cui, {Jian Guo} and Xiong Zhang and Zhao, {Yu Hai} and Chu Chen and Nicolas Bazan",
year = "2006",
month = "11",
day = "17",
doi = "10.1016/j.bbrc.2006.09.055",
language = "English",
volume = "350",
pages = "358--363",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Allodynia and hyperalgesia suppression by a novel analgesic in experimental neuropathic pain

AU - Cui, Jian Guo

AU - Zhang, Xiong

AU - Zhao, Yu Hai

AU - Chen, Chu

AU - Bazan, Nicolas

PY - 2006/11/17

Y1 - 2006/11/17

N2 - SCP-1, n-[α-(benzisothiazol-3(2ho-ona,1-dioxide-2yl)-acetyl]-p-aminophenol (100 nmol), when intrathecally injected, suppressed tactile allodynia and thermal hyperalgesia in a rat neuropathic pain model. The tactile allodynia suppression lasted for at least 4 h and SCP-M1 (100 nmol), the main metabolite of SCP-1, displayed similar suppression as SCP-1, but shorter latency, indicating SCP-M1 may be the bioactive component of SCP-1. Acetaminophen was less potent than SCP-1 and SCP-M1. To study mechanisms underlying SCP-1 action, we recorded voltage-gated Ca2+ channel currents in acutely isolated dorsal root ganglion neurons using the whole-cell patch-clamp technique. SCP-1 and SCP-M1 inhibited non-L-type calcium channel currents up to 23.0 ± 2.3% and 23.1 ± 3.5%, respectively, at a depolarized pulse to -10 mV from a holding potential of -80 mV. Acetaminophen only induced 6.8 ± 1.0% inhibition. The results suggest SCP-1 possesses anti-nociceptive activity in the rat model involving calcium channel blocking properties.

AB - SCP-1, n-[α-(benzisothiazol-3(2ho-ona,1-dioxide-2yl)-acetyl]-p-aminophenol (100 nmol), when intrathecally injected, suppressed tactile allodynia and thermal hyperalgesia in a rat neuropathic pain model. The tactile allodynia suppression lasted for at least 4 h and SCP-M1 (100 nmol), the main metabolite of SCP-1, displayed similar suppression as SCP-1, but shorter latency, indicating SCP-M1 may be the bioactive component of SCP-1. Acetaminophen was less potent than SCP-1 and SCP-M1. To study mechanisms underlying SCP-1 action, we recorded voltage-gated Ca2+ channel currents in acutely isolated dorsal root ganglion neurons using the whole-cell patch-clamp technique. SCP-1 and SCP-M1 inhibited non-L-type calcium channel currents up to 23.0 ± 2.3% and 23.1 ± 3.5%, respectively, at a depolarized pulse to -10 mV from a holding potential of -80 mV. Acetaminophen only induced 6.8 ± 1.0% inhibition. The results suggest SCP-1 possesses anti-nociceptive activity in the rat model involving calcium channel blocking properties.

KW - Behavioral test

KW - Calcium channel

KW - Neuropathic pain

KW - Patch-clamp

KW - Rat

KW - SCP-1

KW - Tactile allodynia

KW - Thermal hyperalgesia

UR - http://www.scopus.com/inward/record.url?scp=33749352912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749352912&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2006.09.055

DO - 10.1016/j.bbrc.2006.09.055

M3 - Article

VL - 350

SP - 358

EP - 363

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -